Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma

por Forlenza, Christopher J., Rosenzweig, Jaclyn, Mauguen, Audrey, Buhtoiarov, Ilia, Cuglievan, Branko, Dave, Hema, Deyell, Rebecca J., Flerlage, Jamie E., Franklin, Anna K., Krajewski, Jennifer, Leger, Kasey J., Marks, Lianna J., Norris, Robin E., Pacheco, Martha, Willen, Faye, Yan, Adam Paul, Harker-Murray, Paul D., Giulino-Roth, Lisa
Publicado 2023

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia

por Dávila Saldaña, Blachy J., John, Tami, Bonifant, Challice, Buchbinder, David, Chandra, Sharat, Chandrakasan, Shanmuganathan, Chang, Weni, Chen, Leon, Elfassy, Hannah L., Geerlinks, Ashley V., Giller, Roger H., Goyal, Rakesh, Hagin, David, Islam, Shahidul, Mallhi, Kanwaldeep, Miller, Holly K., Owen, William, Pacheco, Martha, Patel, Niraj C., Querfeld, Christiane, Quigg, Troy, Richard, Nameeta, Schiff, Deborah, Shereck, Evan, Stenger, Elizabeth, Jordan, Michael B., Heslop, Helen E., Bollard, Catherine M., Cohen, Jeffrey I.
Publicado 2022